Align Technology, Inc.
ALGN Healthcare Medical Instruments & Supplies
Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024. In the quarter to June 2026, revenue grew 4.32%, EPS fell 12.2% and free cash flow grew 85.8%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow ALGN
Align Technology, Inc. (ALGN) Price to free cash flow
As of 16 October 2026, Align Technology, Inc. (ALGN) trades at a price to free cash flow of 15.6×. Over the past ten years it has ranged from 14.3× (September 2025) to 132× (October 2018); the current reading is higher than 1% of that period. That is below the Medical Instruments & Supplies industry median of 25.2× and below the Healthcare sector median of 20.2×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 23.1× | (7.95%) |
| FY2024 | 25.1× | (25.82%) |
| FY2023 | 33.8× | (43.63%) |
| FY2022 | 60.0× | (10.81%) |
| FY2021 | 67.2× | (18.97%) |
| FY2020 | 83.0× | 123.71% |
| FY2019 | 37.1× | (26.71%) |
| FY2018 | 50.6× | (31.69%) |
| FY2017 | 74.1× | 69.41% |
| FY2016 | 43.7× | 53.18% |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Jun 2026 | 17.8× | (14.92%) |
| Mar 2026 | 21.0× | (9.11%) |
| Dec 2025 | 23.1× | 44.30% |
| Sep 2025 | 16.0× | (26.48%) |
| 42 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| SOLV Solventum Corporation compare | n/m |
| ALGN Align Technology, Inc. | 15.6× |
| BAX Baxter International Inc. compare | 16.1× |
| COO The Cooper Companies, Inc. compare | 16.5× |
| AVTR Avantor, Inc. compare | 24.4× |
| ATR AptarGroup, Inc. compare | 25.2× |
| TFX Teleflex Incorporated compare | 33.7× |
| BLCO Bausch + Lomb Corporation compare | 52.3× |
| RGEN Repligen Corporation compare | 162× |
| Medical Instruments & Supplies industry median | 25.2× |
| Healthcare sector median | 20.2× |
| Market median | 14.2× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on ALGN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement